FDA Guidance for Industry: Pediatric Rare Diseases — A Collaborative Approach for Drug Development Using Gaucher Disease as a Model

Titel:
FDA Guidance for Industry: Pediatric Rare Diseases — A Collaborative Approach for Drug Development Using Gaucher Disease as a Model
Herkunft/Verlag:

FDA, https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM587660.pdf

Inhalt:
The purpose of this guidance is to facilitate drug development in pediatric rare diseases.

Zurück

GMP Seminare nach Thema